News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
542,073 Results
Type
Article (17104)
Company Profile (174)
Press Release (524791)
Multimedia
Podcasts (34)
Webinars (11)
Section
Business (182239)
Career Advice (542)
Deals (27462)
Drug Delivery (63)
Drug Development (60124)
Employer Resources (30)
FDA (11463)
Job Trends (9861)
News (263264)
Policy (21625)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (1119)
Accelerated approval (37)
ADA (22)
Adcomms (12)
Allergies (151)
Alliances (38194)
ALS (154)
Alzheimer's disease (1268)
Antibody-drug conjugate (ADC) (392)
Approvals (11919)
Artificial intelligence (561)
ASCO (202)
Autoimmune disease (289)
Automation (49)
Bankruptcy (271)
Best Places to Work (7898)
BIO (51)
Biologics (3)
BIOSECURE Act (19)
Biosimilars (226)
BioSpace Insights (58)
Biotechnology (119)
Bladder cancer (152)
Brain cancer (47)
Breast cancer (628)
Cancer (4520)
Cardiovascular disease (286)
Career advice (455)
Career pathing (13)
CAR-T (216)
CDC (13)
Celiac Disease (1)
Cell therapy (671)
Cervical cancer (37)
Clinical research (53831)
Collaboration (1739)
Commercialization (4)
Company closure (3)
Compensation (1507)
Complete response letters (66)
COVID-19 (1261)
CRISPR (87)
C-suite (967)
Cystic fibrosis (115)
Data (6802)
Denatured (12)
Depression (111)
Dermatology (85)
Diabetes (410)
Diagnostics (4732)
Digital health (46)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (317)
Drug pricing (48)
Drug shortages (2)
Duchenne muscular dystrophy (234)
Earnings (76913)
Editorial (27)
Employer branding (5)
Employer resources (29)
Events (94918)
Executive appointments (864)
FDA (14586)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (25)
Funding (1297)
Gene editing (185)
Generative AI (47)
Gene therapy (513)
GLP-1 (448)
Government (2097)
Grass and pollen (2)
Guidances (327)
Healthcare (10583)
Hematology (123)
HIV (64)
Huntington's disease (47)
IgA nephropathy (89)
Immunology and inflammation (194)
Immuno-oncology (88)
Indications (186)
Infectious disease (1513)
Inflammatory bowel disease (188)
Inflation Reduction Act (10)
Influenza (102)
Intellectual property (280)
Interviews (63)
IPO (13133)
IRA (17)
Job creations (2297)
Job search strategy (427)
JPM (13)
Kidney cancer (18)
Labor market (15)
Layoffs (146)
Leadership (5)
Legal (5498)
Licensing (9)
Liver cancer (54)
Longevity (30)
Lung cancer (616)
Lymphoma (306)
Machine learning (49)
Management (7)
Manufacturing (863)
Marketing (10)
MASH (148)
Medical device (9185)
Medtech (9340)
Mergers & acquisitions (15454)
Metabolic disorders (908)
mRNA (111)
Multiple sclerosis (155)
NASH (9)
Neurodegenerative disease (330)
Neuropsychiatric disorders (47)
Neuroscience (2428)
NextGen: Class of 2026 (3695)
Non-profit (1395)
Now hiring (29)
Obesity (313)
Opinion (109)
Ovarian cancer (185)
Pain (202)
Pancreatic cancer (234)
Parkinson's disease (284)
Partnered (24)
Patents (528)
Patient recruitment (604)
Peanut (58)
People (46411)
Pharmaceutical (36)
Pharmacy benefit managers (11)
Phase 1 (17359)
Phase 2 (23818)
Phase 3 (16763)
Pipeline (8667)
Policy (167)
Postmarket research (1737)
Preclinical (7574)
Press Release (68)
Prostate cancer (216)
Psychedelics (18)
Radiopharmaceuticals (221)
Rare diseases (839)
Real estate (3726)
Recruiting (11)
Regulatory (18204)
Reports (26)
Research institute (1174)
Resumes & cover letters (73)
Rett syndrome (44)
RNA editing (15)
RSV (60)
Schizophrenia (125)
Series A (237)
Series B (163)
Service/supplier (5)
Sickle cell disease (84)
Special edition (7)
Spinal muscular atrophy (110)
Sponsored (25)
Startups (2587)
State (1)
Stomach cancer (8)
Supply chain (71)
Tariffs (21)
The Weekly (22)
Vaccines (612)
Venture capital (47)
Weight loss (126)
Women's health (95)
Worklife (3)
Date
Today (13)
Last 7 days (280)
Last 30 days (1897)
Last 365 days (22897)
2026 (15013)
2025 (22596)
2024 (26485)
2023 (30300)
2022 (39074)
2021 (41734)
2020 (37713)
2019 (27201)
2018 (20412)
2017 (21900)
2016 (20932)
2015 (27360)
2014 (23905)
2013 (20081)
2012 (21990)
2011 (22354)
2010 (21597)
Location
Africa (344)
Alabama (83)
Alaska (3)
Arizona (332)
Arkansas (13)
Asia (23677)
Australia (2952)
California (13140)
Canada (3364)
China (908)
Colorado (518)
Connecticut (456)
Delaware (309)
Europe (39834)
Florida (1875)
Georgia (408)
Hawaii (4)
Idaho (53)
Illinois (803)
India (91)
Indiana (378)
Iowa (19)
Japan (457)
Kansas (107)
Kentucky (38)
Louisiana (35)
Maine (42)
Maryland (1478)
Massachusetts (9035)
Michigan (322)
Minnesota (626)
Mississippi (7)
Missouri (102)
Montana (21)
Nebraska (13)
Nevada (125)
New Hampshire (67)
New Jersey (2964)
New Mexico (17)
New York (3164)
North Carolina (1445)
North Dakota (11)
Northern California (6654)
Ohio (330)
Oklahoma (21)
Oregon (33)
Pennsylvania (2390)
Puerto Rico (25)
Rhode Island (39)
South America (542)
South Carolina (79)
South Dakota (1)
Southern California (5363)
Tennessee (133)
Texas (2067)
United States (43361)
Utah (407)
Vermont (1)
Virginia (186)
Washington D.C. (49)
Washington State (1030)
West Virginia (2)
Wisconsin (99)
Wyoming (1)
542,073 Results for "abcellera biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Women’s health
AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes
AbCellera Biologics’ reduction in hot flashes sets it apart from currently commercial oral drugs, including Astellas’ Veozah and Bayer’s Lynkuet, according to BMO Capital Markets.
August 11, 2026
·
1 min read
·
Tristan Manalac
Press Releases
AbCellera Reports Q2 2026 Business Results
August 5, 2026
·
10 min read
Deals
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B
Jazz Pharmaceuticals is diversifying its oncology strategy, orchestrating a new antibody deal with AbCellera that offers $56 million upfront, plus $792 million in biobucks for each of the three initial programs.
June 17, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
August 11, 2026
·
4 min read
Press Releases
AbCellera Appoints Dr. Lynn Seely to its Board of Directors
July 6, 2026
·
2 min read
Press Releases
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
August 13, 2026
·
4 min read
Press Releases
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
July 7, 2026
·
1 min read
Press Releases
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
June 7, 2026
·
2 min read
Press Releases
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026
·
4 min read
Press Releases
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026
·
3 min read
1 of 54,208
Next
